Skip to content
Open access

Impact of Vitamin D Deficiency on the Efficacy of Atorvastatin in Iraqi Patients with Dyslipidemia

Sep 2026 · Iraqi Journal of Pharmaceutical Sciences · Vol 35, pp. 38-45 · 0 citations · 27 references

TL;DR

Vitamin D3 deficiency significantly reduces the effectiveness of atorvastatin (ATO) in Iraqi patients with dyslipidemia, and there was a significant association between vitamin D3 deficiency and the efficacy of atorvastatin at P <0.05.

Abstract

Dyslipidemia is an abnormal elevation of lipid levels in the blood, which may involve cholesterol and triglycerides. The response of dyslipidemia to statin therapy is diverse, ranging from 5-70% and this may be related to vitamin D3 deficiency. A study aims to assess the effect of vitamin D3 deficiency on the therapeutic response to atorvastatin. The cohort study involved 243 dyslipidemic patients who received different doses of atorvastatin according to the 2018 American Heart Association/American College of Cardiology cholesterol guidelines. The serum lipid profile level, vitamin D3, and atherogenic index were measured. The serum level of Total cholesterol and low-density lipoprotein-cholesterol, and atherogenic index were significantly reduced, and the serum level of high-density lipoprotein-cholesterol was elevated considerably in the responded patients compared to the non-responded patients at P <0.05. The serum level of vitamin D3 was significantly low in the non-responded patients compared to respond patients at P <0.05. There was a significant association between vitamin D3 deficiency (95% CI 0.759 – 0.849) and a decrease in the efficacy of atorvastatin at P <0.05. In conclusion, Vitamin D3 deficiency significantly reduces the effectiveness of atorvastatin (ATO) in Iraqi patients with dyslipidemia.

Read PDF

Similar papers

Review Oct 2026

The effect of evinacumab on the clinical outcomes of dyslipidemia: A systematic review of randomized controlled trials.

BACKGROUND Residual atherosclerotic cardiovascular disease risk remains substantial despite optimal conventional lipid-lowering therapy, particularly in patients with persistently elevated low-density lipoprotein cholesterol (LDL-C). Evinacumab, a monoclonal antibody targeting angiopoietin-like protein 3, represents a...

R. Shahid, Syed Mohammad Habib, M. Awan et al. · 0 citations
Review Open access Sep 2026

[The significance of vitamin D for well-being and the prevention of selected diseases in elderly people: a narrative review].

As civilization progress, the number of older people is constantly growing. Furthermore, they suffer a higher burden of comorbidity and polipharmacy, which has a significant impact on the overall well-being of people in this age group. Elderly people are at risk of vitamin D deficiency, which is necessary for the prope...

Aldona Molęda, Marzena Majchrowska, Aleksandra Kuzan · 0 citations
Open access Sep 2026

The Effect Of Black Cumin Capsules On LDL Levels In Elderly Patients With Hypercholesterolemia At The Pegajahan Community Health Center

Hypercholesterolemia is characterized by increased levels of LDL, total cholesterol, triglycerides, and decreased levels of HDL, caused by various variables, one of which is age. With age, a person's ability to bind to the LDL receptor decreases. This results in an increase in the amount of LDL present in the blood whi...

Shella Amanda, S. Rahmat · 0 citations
Open access Oct 2026

Correlation between serum Vitamin D levels and lipid profile in patients with obesity undergoing metabolic bariatric surgery

Introduction: Roux-en-Y gastric bypass demonstrates high efficacy in reversing vitamin D deficiency and improving the lipid profile in obese patients, thereby reducing cardiovascular risks. The high prevalence of dyslipidemia and cardiovascular risk associated with obesity constitute a serious public health problem, a...

Flaviana Freitas Pedron, Glauco da Costa Alvarez, L. Patias et al. · 0 citations
Open access Sep 2026

Dyslipidemia as a Predictor of Liver Dysfunction, Glycaemic Control and Insulin Resistance: A Cross-Sectional Study

Dyslipidemia (DL), a common metabolic disorder, negatively influences the regulation of glycemia, liver function and insulin sensitivity and is a crucial factor in the dramatic increase in metabolic diseases. In India, the prevalence ranges from 15–20% in rural populations to 25–30% indicating the wide-spread prevalenc...

Naveen Kumar Billa, Darapuneni Radhika Chowdary, Sainath S. B. et al. · 0 citations
Open access Oct 2026

Antioxidant and Lipid-lowering Effect of Sikanjabīn Lemūnī (Oxymel) in the Management of Dyslipidemia

Dyslipidemia, a major risk factor for cardiovascular diseases (CVDs), is characterized by abnormal lipid metabolism, typically presenting as elevated triglycerides, total cholesterol, low-density lipoprotein, and/or decreased high-density lipoprotein. In the Unani (Greco-Arabic) system of medicine, dyslipidemia is...

M. M. Ahmed, M. Khan, Syed Farhanda Farooq et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.